Department Section of Neurointervention, Semmelweis University Department of Neurosurgery, National Institute of Clinical Neurosciences, Budapest, Hungary.
EuroIntervention. 2020 Dec 18;16(12):e1021-e1028. doi: 10.4244/EIJ-D-19-00519.
Our aim was to study the effectiveness of coronary stent implantation during the endovascular treatment (EVT) of acute basilar artery occlusion (BAO) with occlusion-underlying intracranial atherosclerotic stenosis (ICAS).
We retrospectively analysed 91 consecutive BAO patients who underwent EVT between February 2014 and January 2019 in a single, high-volume neurointerventional centre. We studied the effect of immediate coronary stent implantation on the clinical outcome of BAO with occlusion-underlying stenosis. BAO patients with underlying ICAS (n=41) were characterised by longer symptom-onset-to-reperfusion times (231 min vs 173 min, p=0.0020), lower TICI 2b-3 reperfusion rates (65.85% vs 90.00%, p=0.0084), and higher overall mortality (HR 2.021, p=0.0417) compared to the BAO cases without ICAS (n=50). The patients undergoing stenting (n=18) had lower residual basilar artery (BA) stenosis (14.7% vs 81.0%, p<0.0001), higher chance for functional recovery (OR 7.6, p=0.0250) and higher chance of survival (HR 4.163, p=0.0026) compared to the BAO-ICAS cases treated without coronary stents (n=21).
The immediate treatment of the occlusion-underlying stenosis with coronary stents and dual antiplatelet therapy (DAPT) in BAO was associated with improved overall survival and better functional outcomes.
本研究旨在探讨血管内治疗(EVT)急性基底动脉闭塞(BAO)合并狭窄时即刻植入冠状动脉支架的有效性,狭窄的病因是颅内动脉粥样硬化(ICAS)。
我们回顾性分析了 2014 年 2 月至 2019 年 1 月在单一大容量神经介入中心接受 EVT 的 91 例连续 BAO 患者。我们研究了即刻冠状动脉支架植入对 BAO 合并狭窄患者临床结局的影响。BAO 合并 ICAS 患者(n=41)的症状发作至再灌注时间更长(231min 比 173min,p=0.0020),TICI 2b-3 再灌注率更低(65.85%比 90.00%,p=0.0084),整体死亡率更高(HR 2.021,p=0.0417),而无 ICAS 的 BAO 患者(n=50)则相反。接受支架置入术的患者(n=18)的基底动脉(BA)残余狭窄程度更低(14.7%比 81.0%,p<0.0001),功能恢复的可能性更高(OR 7.6,p=0.0250),生存率更高(HR 4.163,p=0.0026),而未接受冠状动脉支架置入术的 BAO-ICAS 患者(n=21)则相反。
BAO 合并狭窄时即刻采用冠状动脉支架置入术联合双联抗血小板治疗(DAPT)治疗闭塞下的狭窄与整体生存和更好的功能结局相关。